as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
11.47%
Downside
0.29%
Upside
52 Week's Low
52 Week's High
44.26%
Downside
81.76%
Upside
Check Recursion Pharmaceuticals-a market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-1.5845
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.41
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-586.4M
Revenue (TTM)
64.6M
Profit Margin
0.00%
Return On Equity TTM
46351000.00%
Track how Recursion Pharmaceuticals-a P/E has moved over time to understand its valuation trends.
Recursion Pharmaceuticals-a in the last 5 years
Lowest (-17.36x)
June 30, 2021
Today (-5.41x)
October 15, 2025
Industry (8.36x)
October 15, 2025
Highest (-2.76x)
June 30, 2025
Today’s Price to Earnings Ratio: -5.41x
Compare market cap, revenue, PE, and other key metrics of Recursion Pharmaceuticals-a with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.4B | NA | -5.41 | 0.00% | |
BUY | $60.9B | 226.08% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $104.4B | 91.48% | 28.99 | 31.86% | |
BUY | $59.1B | -2.15% | 14.07 | 31.37% |
The Recursion Pharmaceuticals-a stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Recursion Pharmaceuticals-a investment value today
Current value as on today
₹1,06,780
Returns
₹6,780
(+6.78%)
Returns from Recursion Pharmaceuticals-a Stock
₹1,949 (+1.95%)
Dollar Returns*
₹4,831 (+4.83%)
Based on 13 analysts
53.85%
Buy
46.15%
Hold
0.00%
Sell
Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Recursion Pharmaceuticals-a. Average target price of $6.47
Get share price movements and forecasts by analysts on Recursion Pharmaceuticals-a.
What analysts predicted
-5.1%DOWNSIDE
Target Price
$6.47
Current Price
$6.8
Analyzed by
13 Analysts
Target
$6.47
Recursion Pharmaceuticals-a target price $6.47, a slight downside of -5.1% compared to current price of $6.8. According to 13 analysts rating.
Investment in Recursion Pharmaceuticals-a Shares on INDmoney has grown by 19.62% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:19.62% versus previous 30 day period
Search interest for Recursion Pharmaceuticals-a Stock has increased by 130% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:130% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 08 October
Wed, 00:21 AM
-Recursion Pharmaceuticals stock surges 17.21% amid strong Q2 revenue, despite missing loss estimates and workforce reduction.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, RXRX stock has moved up by 23.5%
Profit Spike
Netprofit is up for the last 2 quarters, -202.48M → -171.89M (in $), with an average increase of 17.8% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 4.51M → 19.10M (in $), with an average increase of 46.1% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 75.0%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 196.9%
Organisation | Recursion Pharmaceuticals-a |
Headquarters | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Industry | Services |
CEO | Dr. Christopher C. Gibson Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. David J. Mauro M.D., Ph.D. | Chief Medical Officer |
Dr. Najat Khan Ph.D. | Chief R&D Officer, Chief Commercial Officer and Director |
Ms. Kristen Rushton M.B.A. | Chief Operating Officer |
Mr. Nathan Hatfield J.D., M.B.A. | Chief Legal Officer & Corporate Secretary |
Ms. Erica Fox | Chief People and Impact Officer |
Mr. Matthew Kinn M.B.A. | Chief Business Officer |
Dr. Christopher C. Gibson Ph.D. | Co-Founder, CEO & Director |
Mr. Ben R. Taylor | CFO & President of Recursion UK |
Mr. Benjamin Mabey M.S. | Chief Technology Officer |
Dr. David Hallett Ph.D. | Chief Scientific Officer |
Recursion Pharmaceuticals-a share price today is $6.8 as on at the close of the market. Recursion Pharmaceuticals-a share today touched a day high of $6.82 and a low of $6.02.
Recursion Pharmaceuticals-a share touched a 52 week high of $12.36 on and a 52 week low of $3.79 on . Recursion Pharmaceuticals-a stock price today i.e. is closed at $6.8,which is 44.98% down from its 52 week high and 79.42% up from its 52 week low.
Recursion Pharmaceuticals-a market capitalisation is $0.00T as on .
Indian investors can start investing in Recursion Pharmaceuticals-a (RXRX) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Recursion Pharmaceuticals-a stock (as per the Rupee-Dollar exchange rate as on ).
Based on Recursion Pharmaceuticals-a share’s latest price of $6.8 as on October 16, 2025 at 1:29 am IST, you will get 1.4706 shares of Recursion Pharmaceuticals-a. Learn more about
fractional shares .